# Recombinant Human Prolactin for Lactation Induction

> **NCT00181610** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 11 (actual)

## Conditions studied

- Lactation

## Interventions

- **DRUG:** Recombinant Human Prolactin
- **BIOLOGICAL:** Recombinant human prolactin
- **BIOLOGICAL:** Normal Saline

## Key facts

- **NCT ID:** NCT00181610
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181610, "Recombinant Human Prolactin for Lactation Induction". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00181610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*